Vitrolife: Soft Genomic Services and Technology - Redeye

Consumables did not make up for a softer period in Genomic Services and Technologies. This is partly related to the comparable US quarter, but the overall result is a softish organic growth of 4% (CER) and both the growth and the margins are below expectations for Vitrolife.

Länk till analysen i sin helhet: https://www.redeye.se/research/922201/soft-genomic-services-and-technology?utm_source=finwire&utm_medium=RSS